Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Osciflex
AddedFeb 16, 2024
UpdatedJun 18, 2026
Osciflex

Osciflex

Osciflex: A compression therapy device manufacturer preventing blood clots naturally.

HQ
Philadelphia, PA, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Founded with the mission to prevent deadly blood clots, Osciflex is a company dedicated to developing advanced compression therapy devices. Their core product, the Osciflex system, mimics natural processes to effectively prevent venous thromboembolism (VTE), a significant cause of complications and mortality in hospitalized patients. By focusing on reducing hospital-associated VTE (HA-VTE), Osciflex aims to improve patient outcomes and reduce healthcare costs.

Osciflex has garnered attention for its innovative approach to compression therapy, attracting notable investors and healthcare professionals committed to enhancing patient care. The company's achievements include the development of a cutting-edge device that addresses a critical healthcare need, positioning them as a key player in the medical device industry. Through their efforts, Osciflex has made a substantial impact on patient safety and hospital efficiency.

Osciflex - Quick Facts

When was Osciflex founded?

Osciflex was founded in 2017.

Where is Osciflex's headquarters located?

Osciflex's headquarters is located in Philadelphia, PA, US.

When was Osciflex's last funding round?

Osciflex's most recent funding round was for $999.7k (USD) in December 2021.

How much has Osciflex raised to-date?

As of Dec 28, 2021, Osciflex has raised a total of $1.2M (USD).

How many employees does Osciflex have?

Osciflex has 7 employees as of Feb 4, 2024.

Osciflex - Classification

Industry
  • Hardware
  • Hospitals
Ownership
  • Private
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 1 more industry code
NAICS
  • 623000Nursing and Residential Care Facilities